Understanding Pancreatic Beta Cell Decompensation: From Progression to T2D Prevention

By Carlos

Overview of Pancreatic Beta Cell Decompensation And Progression To T2D

Pancreatic beta cell decompensation and progression to T2D
Pancreatic beta cell decompensation and progression to T2D

Pancreatic β- cells control glucose homeostasis by secreting insulin and dysfunction to such metabolic regulation emerges as a pivotal contributor to the development of type 2 diabetes ( T2D ). Irreversible cell cycle arrest, altered secretory patterns, and decreased proliferative capacity characterize aspects of pancreatic beta cell senescence.

A Immunohistochemical quantification of Aβ 1 42 plaques
A Immunohistochemical quantification of Aβ 1 42 plaques

This article aims to delineate the key nodes in the transition of beta cells from physiological to pathological metabolic states, providing a theoretical basis for identifying reversible stages in disease progression and restoring metabolic flexibility to achieve beta cell functional protection.

Pancreatic Beta

Functional role of T2D relevant IFGs identified by Vec2image
Functional role of T2D relevant IFGs identified by Vec2image

Pancreatic β- cells produce and secrete insulin to maintain blood glucose levels within a narrow range. Defects in the function and mass of β- cells play a significant role in the development and progression of diabetes. Increased β- cell deficiency and β- cell apoptosis are observed in the pancreatic islets of patients with type 2 diabetes. At an early stage, β- cells adapt to insulin ...

Type 2 diabetes ( T2D ) has been considered a relentlessly worsening disease, due to the progressive deterioration of the pancreatic beta cell functional mass. Recent evidence indicates, however, that remission of T2D may occur in variable proportions of patients after specific treatments that are associated with recovery of beta cell function.

Plasma exosomes from T2D subjects induce major features of tumor cell
Plasma exosomes from T2D subjects induce major features of tumor cell

Useful Notes on Pancreatic Beta Cell Decompensation And Progression To T2D

In conclusion, β- cell dedifferentiation represents a critical frontier in diabetes research, with the potential to reshape our understanding of both T1D and T2D . The reversibility of this process holds immense promise for developing therapies that preserve or restore β- cell function.

Abstract Type 2 diabetes ( T2D ) is caused by insulin resistance and insufficient insulin secretion. Evidence has increasingly indicated that pancreatic β- cell dysfunction is the primary determinant of T2D disease progression and remission. High plasticity is an important feature of pancreatic β- cells .

Animal Models for Understanding the Mechanisms of Beta Cell Death
Animal Models for Understanding the Mechanisms of Beta Cell Death

Reversing pancreatic

Diabetes develops when glucose homeostasis fails. Type 2 diabetes ( T2D ) is characterized by insulin resistance and pancreatic β- cell failure.

T2D accounts for nearly 90% of all diabetes cases and is marked by peripheral insulin resistance and subsequent pancreatic - cell failure2. - cells upregulate their β β insulin production and /or ...

Frontiers
Frontiers

Key Details About Pancreatic Beta Cell Decompensation And Progression To T2D

T2D is a metabolic disorder driven by polygenes and environmental risk factors, which is characterized by impaired insulin secretion arising from progressive pancreatic β- cell dysfunction and loss of β- cell mass and insulin resistance in the target peripheral tissues, resulting in multiple long-term health complications ( 3 - 5 ).

Schematic diagram of the mechanisms of oral anti CD3 plus GC
Schematic diagram of the mechanisms of oral anti CD3 plus GC
T2D risk variants affect beta cell subtype chromatin accessibility
T2D risk variants affect beta cell subtype chromatin accessibility
Cellular senescence in type 2 diabetes T2D Accelerated cellular
Cellular senescence in type 2 diabetes T2D Accelerated cellular
Signaling pathways of obese T2D immune cell MNC MP
Signaling pathways of obese T2D immune cell MNC MP
T2D plasma exosomes require BRD4 to upregulate EMT genes and PD L1
T2D plasma exosomes require BRD4 to upregulate EMT genes and PD L1
Schematic image presenting a model for how the T2D associated changes
Schematic image presenting a model for how the T2D associated changes

Type 2 diabetes results from a combination of insulin resistance and dysfunction of insulin-producing pancreatic beta cells . Insulin deficiency is thought to be caused by both beta-cell ...